Celon Pharma S.A. (FRA:8RP)

Market Cap	267.84M
Revenue (ttm)	52.87M
Net Income (ttm)	-28.68M
Shares Out	n/a
EPS (ttm)	-0.55
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60
Average Volume	3
Open	5.000
Previous Close	4.655
Day's Range	4.950 - 5.000
52-Week Range	4.265 - 6.650
Beta	n/a
RSI	61.38
Earnings Date	Apr 28, 2026

About Celon Pharma

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o.

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 558
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8RP

Financial Performance

In 2024, Celon Pharma's revenue was 205.55 million, a decrease of -4.25% compared to the previous year's 214.66 million. Losses were -34.45 million, 22.5% more than in 2023.

Financial numbers in PLN